Literature DB >> 25992197

Anaemia in Waldmann's disease: A rare presentation of a rare disease.

Shahira A El-Etreby1, Ahmed Y Altonbary1, Mohamed El Sorogy1, Wagdi Elkashef1, Jehan A Mazroa1, Monir H Bahgat1.   

Abstract

A 32-year-old female presented with 5-year history of iron deficiency anemia, marked pallor and edema of both lower limbs. Laboratory investigations including complete blood count, blood film, iron studies, lipid profile, ascitic fluid analysis, test of stool for occult blood and alpha 1 anti-trypsin. Upper, lower gastrointestinal (GIT) endoscopies, and enteroscopy were performed. Imaging techniques as abdominal ultrasonography and computed tomography were done. Echocardiography, lymph node biopsy and bone marrow examination were normal. The case was diagnosed as Waldmann's disease with protein losing enteropathy and recurrent GIT bleeding. Management started with low fat diet with medium chain triglyceride, octreotide 200 μg twice a day, tranexamic acid and blood transfusion. Then, exploratory laparotomy with pathological examination of resected segment was done when recurrent GIT bleeding occurred and to excluded malignant transformation.

Entities:  

Keywords:  Gastrointestinal bleeding; Iron deficiency anemia; Lymphangiectasia; Waldmann’s disease

Year:  2015        PMID: 25992197      PMCID: PMC4436926          DOI: 10.4253/wjge.v7.i5.567

Source DB:  PubMed          Journal:  World J Gastrointest Endosc


  35 in total

1.  Type I intestinal lymphangiectasia treated successfully with slow-release octreotide.

Authors:  R D Klingenberg; N Homann; D Ludwig
Journal:  Dig Dis Sci       Date:  2003-08       Impact factor: 3.199

2.  The role of the gastrointestinal system in "idiopathic hypoproteinemia".

Authors:  T A WALDMANN; J L STEINFELD; T F DUTCHER; J D DAVIDSON; R S GORDON
Journal:  Gastroenterology       Date:  1961-09       Impact factor: 22.682

3.  Enteral nutrition as a primary therapy for intestinal lymphangiectasia: value of elemental diet and polymeric diet compared with total parenteral nutrition.

Authors:  Kunihiko Aoyagi; Mitsuo Iida; Takayuki Matsumoto; Shotaro Sakisaka
Journal:  Dig Dis Sci       Date:  2005-08       Impact factor: 3.199

4.  Chylous reflux into abdominal skin simulating lymphangioma circumscriptum in a patient with primary intestinal lymphangiectasia.

Authors:  J B O'Driscoll; R J Chalmers; T W Warnes
Journal:  Clin Exp Dermatol       Date:  1991-03       Impact factor: 3.470

5.  Bilateral breast edema in intestinal lymphangiectasia.

Authors:  Cihan Goktan; Gokhan Pekindil; Sebnem Orguc; Teoman Coskun; Selim Serter
Journal:  Breast J       Date:  2005 Sep-Oct       Impact factor: 2.431

6.  Intestinal lymphangiectasia markedly improved with antiplasmin therapy.

Authors:  K Mine; S Matsubayashi; Y Nakai; T Nakagawa
Journal:  Gastroenterology       Date:  1989-06       Impact factor: 22.682

7.  Alpha 1-antitrypsin, a reliable endogenous marker for intestinal protein loss and its application in patients with Crohn's disease.

Authors:  U Karbach; K Ewe; H Bodenstein
Journal:  Gut       Date:  1983-08       Impact factor: 23.059

8.  Alpha 1-antitrypsin excretion in stool in normal subjects and in patients with gastrointestinal disorders.

Authors:  B Strygler; M J Nicar; W C Santangelo; J L Porter; J S Fordtran
Journal:  Gastroenterology       Date:  1990-11       Impact factor: 22.682

9.  Primary intestinal and thoracic lymphangiectasia: a response to antiplasmin therapy.

Authors:  Joanna E MacLean; Eyal Cohen; Michael Weinstein
Journal:  Pediatrics       Date:  2002-06       Impact factor: 7.124

10.  Intestinal lymphangiectasia. Long-term results with MCT diet.

Authors:  W L Tift; J K Lloyd
Journal:  Arch Dis Child       Date:  1975-04       Impact factor: 3.791

View more
  1 in total

Review 1.  Primary intestinal lymphangiectasia in an adult patient: A case report and review of literature.

Authors:  Rudolf Huber; Georg Semmler; Alexander Mayr; Felix Offner; Christian Datz
Journal:  World J Gastroenterol       Date:  2020-12-08       Impact factor: 5.742

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.